Open AccessEvaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography
Author(s) -
Manoj Gupta,
Partha Sarathi Choudhury,
Sudhir Rawal,
Harish Chandra Goel,
Shriram Avinash Rao
Publication year - 2019
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/ua.ua_111_18
Subject(s) - prostate cancer , medicine , response evaluation criteria in solid tumors , positron emission tomography , glutamate carboxypeptidase ii , nuclear medicine , cancer , oncology , progressive disease , disease
We evaluated various morphological and molecular response criteria in metastatic castration-resistant prostate cancer (PCa) patient undergoing peptide receptor radioligand therapy (PRLT) with Lutetium177-prostate-specific membrane antigen (PSMA) by using Gallium 68-PSMA positron-emission tomography-computed tomography (Ga68-PSMA PET-CT).